[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346419-105":59,"doc-detail-346419-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","association-of-a-cancer-diagnosis-and-mortality-after-ischemic-and-hemorrhagic-stroke-and-myocardial-infarction","Association of a Cancer Diagnosis and Mortality After Ischemic and Hemorrhagic Stroke and Myocardial Infarction","","Study examines whether a cancer diagnosis changes mortality outcomes after ischemic stroke, hemorrhagic stroke, and myocardial infarction (MI). A population-based cohort study in Taiwan used linked national databases from 2011–2019, applying propensity score matching to estimate 90-day mortality odds ratios for all cancers combined and 15 cancer types. Excess mortality was assessed over time after cancer diagnosis by age group, cancer stage, and cancer type. Results show higher 90-day mortality with cancer across all three cohorts, highest for aggressive malignancies, with excess mortality peaking in the first postdiagnosis year and generally within 2 years.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/association-of-a-cancer-diagnosis-and-mortality-after-ischemic-and-hemorrhagic-stroke-and-myocardial-infarction/346419/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/association-of-a-cancer-diagnosis-and-mortality-after-ischemic-and-hemorrhagic-stroke-and-myocardial-infarction/346419.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the primary outcome in the study?","Question",{"text":113,"@type":114},"The primary outcome was 90-day mortality after the index event date (stroke for the stroke cohorts and MI for the MI cohort).","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were the risks of mortality estimated for cancer patients?",{"text":118,"@type":114},"Odds ratios of 90-day mortality were estimated for all cancers combined and 15 cancer types using propensity score matching to address confounding variables.",{"name":120,"@type":111,"acceptedAnswer":121},"When did excess mortality after cancer diagnosis tend to peak?",{"text":122,"@type":114},"Excess mortality rates were highest during the first postdiagnosis year and typically peaked within 2 years, with the highest rates among ages 18–59 and stage 4 disease.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},346419,1790265787,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","RESEARCH ARTICLE  OPEN ACCESS  \nAssociation of a Cancer Diagnosis and Mortality After Ischemic and Hemorrhagic Stroke and Myocardial Infarction  \nYen-Ta Huang,1 Michael Chun-Yuan Cheng,2,3 Cheng-Yang Hsieh,4 Ching-Han Lai,5 Yu-Min Yeh,6 Avery Shuei-He Yang,2,3 Yu Shyr,7 Edward Chia-Cheng Lai,2,3,* and Chao-Han Lai1,3,7,8,*  \nNeurology ® 2026;106:e214649 . doi:10 . 1212/WNL.0000000000214649  \nAbstract  \nBackground and Objectives  \nPrevious studies have indicated an increased risk of cerebrovascular and coronary events shortly after cancer diagnosis. However, whether cancer aﬀects mortality outcomes after stroke and myocardial infarction (MI) remains unclear. We aimed to investigate the relationship between cancer diagnosis and mortality after stroke and MI.  \nMethods  \nUsing linked nationwide databases from Taiwan, we conducted a population-based cohort study including 3 cohorts of patients withﬁrst-time ischemic stroke, hemorrhagic stroke, and MI between 2011 and 2019. The primary outcome was 90-day mortality, with follow-up beginning at the index stroke (for ischemic and hemorrhagic stroke cohorts) and MI (for the MI cohort) event date for all patients. Odds ratios (ORs) of 90-day mortality associated with all cancers combined and 15 cancer types were estimated through propensity score matching for potential confounding variables. Excess mortality rates (between patients with cancer and matched controls) were analyzed across time intervals after cancer diagnosis, stratiﬁed by age group, cancer stage, and cancer type.  \nResults  \nOverall, 440,664, 159,606, and 228,993 patients were included in ischemic stroke (mean age, 70.1 years; 40.7% female), hemorrhagic stroke (mean age, 65.4 years; 36.5% female), and MI (mean age, 67.8 years; 29.7% female) cohorts, respectively. Compared with matched controls, patients with cancer had higher risks of 90-day mortality in ischemic stroke (OR 2.71, 95% CI 2.63–2.79), hemorrhagic stroke (OR 2.20, 95% CI 2.11–2.29), and MI (OR 1.63, 95% CI 1.57–1.69). Across 3 cohorts, substantial variations existed among cancer types, with aggressive malignancies (e.g., pancreatic cancer) consistently presenting the highest risks. Excess mortality rates were highest during the ﬁrst postdiagnosis year and declined progressively thereafter. This temporal pattern was consistent across age groups and cancer stages, with excess mortality rates highest among patients aged 18–59 years and those with stage 4 disease. Despite variability among cancer types, excess mortality typically peaked within 2 years.  \nDiscussion  \nThis population-based study showed that patients with cancer had higher risks ofmortality after stroke and MI, with substantial variations by cancer type, although cause-speciﬁc mortality data were lacking. Excess mortality rates peaked shortly after diagnosis, particularly for early-onset cancer and advanced disease.  \nCorrespondence Dr. Lai  \nd303878@ [mail.hosp.ncku.edu.tw](mail.hosp.ncku.edu.tw)  \nMORE ONLINE  \nSupplementary Material  \n*These authors contributed equally to this work as co-senior authors.  \n1Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; 2School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan; 3Population Health Data Center, National Cheng Kung University, Tainan, Taiwan;4Department of Neurology, Tainan Sin Lau Hospital, Taiwan; 5Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; 6Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; 7Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN; and 8Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.","cbCaiudAwQPi1Xxo","https://ap.wps.com/l/cbCaiudAwQPi1Xxo","pdf",1604831,13,"English","# Abstract\n## Background and Objectives\n## Methods\n## Results\n## Discussion\n# Introduction","[{\"question\":\"What was the primary outcome in the study?\",\"answer\":\"The primary outcome was 90-day mortality after the index event date (stroke for the stroke cohorts and MI for the MI cohort).\"},{\"question\":\"How were the risks of mortality estimated for cancer patients?\",\"answer\":\"Odds ratios of 90-day mortality were estimated for all cancers combined and 15 cancer types using propensity score matching to address confounding variables.\"},{\"question\":\"When did excess mortality after cancer diagnosis tend to peak?\",\"answer\":\"Excess mortality rates were highest during the first postdiagnosis year and typically peaked within 2 years, with the highest rates among ages 18–59 and stage 4 disease.\"}]","Association of a Cancer Diagnosis and Mortality After Ischemic and Hemorrhagic Stroke and Myocardial Infarction | PDF",1790061370,33,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38b7f4e52d8a5cc2e6c6d570ade518c7.webp",983,1295,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5592151a68b41ca6310b5e37e3b2d2dc.webp",982,1293,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4cb2c445b8faa1d805c599cecac5a2d8.webp",981,1292,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9dd17f9951d79e5e3fb44d0163f1bbac.webp",980,1291]